More bad news for drug eluting stents , as new dangers emerge in the form of “late stent malapposition”
Posted Jan 17 2010 10:26am
Drug eluting stents have taken the cardiology community by storm . Millions of drug eluting stents are implanted every year. Sudden stent occlusion without any warning has been the major threat of DES. Dependence of these patients , on meticulous dual anitplatelet therapy is another important caveat .This issue gets further complicated as we recognise “ clopidogrel resistance” in many of this population . This , in effect pushes these DES patients back into higher risk category.
So the cardiology community cannot afford to shy away from answering the following vital questions !
How safe is DES in the long run ? Are we really convinced ? Is it acceptable to leave a DES patient’s life at the mercy of clopidogrel which has it’s own idiosyncratic behavior ?
While this debate is getting hot , this new year( 2010) , there is further bad news for DES .
Read this article from European heart journal 2010